Cardinal Health Inc.
Cardinal Health Updates Fiscal Year 2025 Non-GAAP EPS Expectations
Summary
Cardinal Health, Inc. updated its fiscal year 2025 non-GAAP diluted earnings per share (EPS) expectations to be toward the high end of the previously provided range of $7.75 to $7.90, driven by strength in the Pharmaceutical and Specialty Solutions segment. The company will present at the JP Morgan 43rd Annual Healthcare Conference on January 14, 2025, and provide further details on its fiscal year 2025 results on its second quarter earnings call on January 30, 2025.
Profitelligence Alerts
Get alerts for CAH
Be first to know when Cardinal Health Inc. files with the SEC.
Filing Categories
Advertisement
About Cardinal Health Inc.
Cardinal Health Inc. is a major global healthcare services and products company, distinguished for providing end-to-end medical solutions. Specializing in healthcare distribution and supply chain management, Cardinal Health serves a comprehensive array of clients including hospitals, pharmacies, and healthcare providers. Notably, the company distributes pharmaceuticals, medical products, and laboratory supplies, ensuring efficient delivery to improve healthcare outcomes. Based in Dublin, Ohio, Cardinal Health plays a pivotal role in enhancing healthcare operational efficiency, offering extensive services like inventory management, logistics optimization, and integrated healthcare solutions that empower providers to focus on patient care. As one of the largest pharmaceutical distributors in the United States, it holds substantial influence in the healthcare sector, pivotal in ensuring the availability of drugs and medical supplies across various platforms, contributing significantly to the healthcare infrastructure worldwide.
Official SEC Documents
Advertisement